Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?

PURPOSE: Radiation therapy (RT) improves control of Hodgkin lymphoma (HL), but patients who undergo RT are at risk for late effects, including cardiovascular disease and second cancers, because of radiation doses to organs at risk (OARs). Proton therapy (PT) can reduce OAR doses compared with conven...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pract Radiat Oncol
Main Authors: Ntentas, Georgios, Dedeckova, Katerina, Andrlik, Michal, Aznar, Marianne C., George, Ben, Kubeš, Jiří, Darby, Sarah C., Cutter, David J.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493042/
https://ncbi.nlm.nih.gov/pubmed/30708133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prro.2019.01.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados